全玻片成像市场规模、份额及成长分析（按技术、应用、最终用户和地区划分）－2026-2033年产业预测

预计到 2024 年，全球全切片成像市场规模将达到 12.7 亿美元，到 2025 年将达到 14.7 亿美元，到 2033 年将达到 47.6 亿美元，在预测期（2026-2033 年）内，复合年增长率为 15.8%。

随着数位病理学技术的进步不断提升诊断的准确性和效率，全球全切片成像市场正经历变革性成长。包括医院、製药公司、生物技术公司和病理检查室在内的众多相关人员都在积极采用这项技术，该技术透过自动化演算法和高速系统显着加快了影像撷取速度。全切片成像技术从传统成像技术发展而来，拓展了其应用范围，在确保高品质结果的同时，实现了更快的诊断。鑑于其重要的临床意义，专业机构已更新指南，确认全切片影像技术在病理诊断中的有效性，以确保患者照护。随着这项技术的不断发展，它有望重新定义病理学，并为医疗服务提供者提供创新工具，以改善患者预后并简化诊疗流程。

全球全切片成像市场驱动因素

慢性疾病（包括癌症）的日益增加凸显了对精准高效诊断方案的需求，使得全切片影像成为病理检查室和医疗专业人员的必备技术。这种对精准诊断日益增长的需求推动了创新成像工具的应用，从而提高了疾病检测的速度和可靠性。随着医疗专业人员致力于改善患者预后，将全切片影像整合到常规病理工作流程中对于促进复杂组织样本的分析和解读至关重要。因此，这一趋势凸显了先进成像技术在现代医学实践和研究中的重要性。

限制全球全切片成像市场的因素

全球全切片成像市场面临处理大量敏感患者数位化资讯的重大挑战。这引发了人们对资料安全和隐私的担忧，相关人员日益关注未授权存取和洩露敏感患者资料的潜在风险。这些担忧构成障碍，可能阻碍全切片成像技术在临床环境中的广泛应用和整合。确保强而有力的安全措施并遵守隐私法规对于应对这些挑战、建立医病信任至关重要。

全球全切片成像市场趋势

全球全切片成像市场正呈现出一个显着的趋势，即全切片成像 (WSI) 系统与实验室资讯系统 (LIS) 和电子健康记录 (EHR) 系统整合。这种整合实现了无缝的数据管理和强大的患者记录管理，从而提高了病理检查室的整体效率。随着医疗机构寻求数位化解决方案来优化诊断流程，WSI 与 LIS/EHR 系统之间的协同作用变得至关重要。这一趋势不仅有助于改善医疗专业人员之间的沟通，还有助于做出更明智的决策，从而改善患者预后并提高临床层面的营运效率。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究

全球全切片成像市场规模（依技术及复合年增长率划分）（2026-2033 年）

• 扫描器
• IT基础设施
• 观众
• 影像管理系统

全球全切片成像市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 远距病理诊断
• 细胞病理学
• 免疫组织化学
• 血液病理学

全球全切片成像市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 製药和生物製药公司
• 研究所
• 学术机构
• 研究
• 其他的

全球全切片成像市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Danaher Corporation（United States）
• Hamamatsu Photonics KK（Japan）
• 3DHISTECH Ltd.（Hungary）
• Olympus Corporation（Japan）
• Roche Holding AG（Switzerland）
• Koninklijke Philips NV（Netherlands）
• Leica Biosystems Nussloch GmbH（Germany）
• PerkinElmer, Inc.（United States）
• Sectra AB（Sweden）
• Diasorin（Italy）
• Biocare Medical（United States）
• Sakura Finetek（Japan）
• DigiPath（United States）
• Indica Labs（Canada）

结论与建议

Global Whole Slide Imaging Market size was valued at USD 1.27 Billion in 2024 and is poised to grow from USD 1.47 Billion in 2025 to USD 4.76 Billion by 2033, growing at a CAGR of 15.8% during the forecast period (2026-2033).

The global whole slide imaging market is experiencing transformative growth, driven by advancements in digital pathology that enhance diagnostic accuracy and efficiency. Diverse stakeholders, including hospitals, pharmaceutical companies, biotech firms, and pathology labs, are leveraging this technology, which significantly accelerates image acquisition through automated algorithms and high-speed systems. The evolution from traditional imaging methods to whole slide imaging has broadened its application scope, facilitating quicker diagnoses while maintaining high-quality results. Recognizing its clinical importance, professional organizations have updated guidelines to validate whole slide imaging for pathology diagnostics, ensuring timely patient care. As this technology continues to evolve, it is set to redefine pathology, empowering healthcare providers with innovative tools for improved patient outcomes and streamlined processes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Whole Slide Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Whole Slide Imaging Market Segments Analysis

Global Whole Slide Imaging Market is segmented by Technology, Application, End User and region. Based on Technology, the market is segmented into Scanners, IT Infrastructure, Viewer and Image Management System. Based on Application, the market is segmented into Telepathology, Cytopathology, Immunohistochemistry and Hematopathology. Based on End User, the market is segmented into Hospitals, Pharmaceutical and Biopharmaceutical Companies, Laboratories, Academic Institute, Research and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Whole Slide Imaging Market

The rising prevalence of chronic diseases, including cancer, underscores the need for precise and efficient diagnostic solutions, positioning Whole Slide Imaging as a vital technology for pathology laboratories and healthcare practitioners. This growing demand for accurate diagnostics drives the adoption of innovative imaging tools that enhance the speed and reliability of disease detection. As healthcare professionals strive for improved patient outcomes, the integration of Whole Slide Imaging into routine pathology workflows becomes crucial, facilitating better analysis and interpretation of complex tissue samples. Consequently, this trend highlights the importance of advanced imaging technologies in contemporary medical practice and research.

Restraints in the Global Whole Slide Imaging Market

The Global Whole Slide Imaging market faces significant challenges due to the handling of substantial volumes of sensitive patient information in a digital format. This creates apprehensions surrounding data security and privacy, as stakeholders are increasingly concerned about the potential risks associated with unauthorized access or breaches of confidential patient data. Such concerns can act as a barrier, hindering the broader acceptance and integration of Whole Slide Imaging technologies in clinical settings. Ensuring robust security measures and compliance with privacy regulations will be essential for addressing these issues and fostering trust among healthcare providers and patients alike.

Market Trends of the Global Whole Slide Imaging Market

The Global Whole Slide Imaging market is experiencing a significant trend towards the integration of Whole Slide Imaging (WSI) systems with Laboratory Information Systems (LIS) and electronic health records (EHR). This integration enhances workflow efficiency by enabling seamless data management and robust patient record-keeping, thus improving overall productivity in pathology labs. As healthcare institutions increasingly seek digital solutions to optimize diagnostic processes, the synergy between WSI and LIS/EHR systems is becoming essential. This trend not only fosters improved communication among healthcare professionals but also supports better decision-making, leading to enhanced patient outcomes and streamlined operations within clinical settings.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies

Global Whole Slide Imaging Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Scanners
• IT Infrastructure
• Viewer
• Image Management System

Global Whole Slide Imaging Market Size by Application & CAGR (2026-2033)

• Market Overview
• Telepathology
• Cytopathology
• Immunohistochemistry
• Hematopathology

Global Whole Slide Imaging Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Pharmaceutical and Biopharmaceutical Companies
• Laboratories
• Academic Institute
• Research
• Others

Global Whole Slide Imaging Market Size & CAGR (2026-2033)

• North America (Technology, Application, End User)
  • US
  • Canada
• Europe (Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamamatsu Photonics K.K. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3DHISTECH Ltd. (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leica Biosystems Nussloch GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sectra AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diasorin (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocare Medical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sakura Finetek (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DigiPath (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indica Labs (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations